0001567619-20-021476.txt : 20201222
0001567619-20-021476.hdr.sgml : 20201222
20201222130957
ACCESSION NUMBER: 0001567619-20-021476
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20201222
DATE AS OF CHANGE: 20201222
EFFECTIVENESS DATE: 20201222
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Soley Therapeutics, Inc.
CENTRAL INDEX KEY: 0001830785
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-384030
FILM NUMBER: 201407164
BUSINESS ADDRESS:
STREET 1: 1 CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (415) 850-9841
MAIL ADDRESS:
STREET 1: 1 CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
D
1
primary_doc.xml
X0708
D
LIVE
0001830785
Soley Therapeutics, Inc.
1 Corporate Drive
South San Francisco
CA
CALIFORNIA
94080
(415) 850-9841
DELAWARE
None
None
Corporation
true
Ken
V.
Alwyn
1 Corporate Drive
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Director
Chief Financial Officer
Kurosh
Ameri
1 Corporate Drive
South San Francisco
CA
CALIFORNIA
94080
Director
Yerem
Yeghiazarians
1 Corporate Drive
South San Francisco
CA
CALIFORNIA
94080
Director
Biotechnology
Decline to Disclose
- 06b
false
2020-10-15
false
true
false
0
20000000
20000000
0
false
32
0
0
0
false
Soley Therapeutics, Inc.
/s/ Ken V. Alwyn
Ken V. Alwyn
Chief Financial Officer
2020-12-18